Scientific Publications and News Articles
- Maternal RSV Task Force Emphasizes the Immediate Opportunity to Protect All Infants in Canada from RSV Disease
- Healthcare Providers and Pregnant People’s Preferences for a Preventive to Protect Infants from Serious Illness Due to Respiratory Syncytial Virus
- Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during the 2024 RSV season in Argentina (BERNI study): a multicentre, retrospective, test-negative, case–control study
- Maternal vaccination to prevent severe RSV disease in infants
- Respiratory syncytial virus vaccination in pregnancy (cmaj.ca)
- Nirsevimab to reduce infant morbidity from respiratory syncytial virus (cmaj.ca)
- New RSV vaccine could prevent 5,000 infant hospitalisations – GOV.UK (www.gov.uk)
- Acceptance and preference between respiratory syncytial virus vaccination during pregnancy and infant monoclonal antibody among pregnant and postpartum persons in Canada – ScienceDirect
- Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial
- Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine
- High Uptake of Respiratory Syncitial Virus Prevention for Neonates in a Military Treatment Facility – ScienceDirect
